Latest for Fanconi Anemia
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Who can joinWho can join changed for Eltrombopag for Fanconi Anemia (Phase 2)ClinicalTrials.gov
More about Fanconi Anemia
The hallmark diagnostic feature is chromosomal breakage induced by diepoxybutane (DEB) or mitomycin C (MMC) testing. Pathophysiology involves impaired DNA crosslink repair, resulting in genomic instability and accumulation of damage in proliferating hematopoietic cells.
Keep reading about Fanconi Anemia
Patients develop progressive bone marrow failure with pancytopenia typically by second decade of life. About 75% have physical abnormalities including short stature, skeletal defects (thumb hypoplasia, radial ray defects, syndactyly), microcephaly, cleft lip/palate, and cardiac, renal, or urogenital anomalies.
Most critically, FA patients have exponentially increased cancer risk with approximately 75% developing solid tumors or hematologic malignancies (acute myeloid leukemia, myelodysplastic syndrome, squamous cell carcinomas) by age 50. Gender ratios approximately equal. Prognosis without transplantation guarded.
What are the symptoms of Fanconi Anemia?
These are common symptoms of Fanconi Anemia, and how strong they are varies from person to person.
- Anemia, thrombocytopenia, neutropenia by age 10
- Progressive bone marrow failure
- Physical abnormalities (short stature, thumb/radial defects)
- Increased bleeding and infections
- Developmental delay in some forms
- Extreme leukemia and solid tumor risk
Who gets Fanconi Anemia?
Typically manifests in first two decades of life with median diagnosis age 7 years. Affects males and females equally. Autosomal recessive inheritance in most types (FA-A most common, ~70% of cases); X-linked inheritance in rare FA-B type.
More common in certain ethnic populations including Ashkenazi Jewish, Hispanic, and South Asian populations. Carrier frequency for FA-A mutations higher in these populations. No geographic clustering beyond ethnic variation. Consanguinity increases incidence.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Fanconi Anemia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Fanconi Anemia resources
Reputable organizations and medical references for learning more about Fanconi Anemia, including disease registries, foundation resources, and clinical guidelines.